BioSpace News Archive

Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces the enrollment of the 60th patient in its Phase 2 double blind, placebo controlled clinical trial of AG013.

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Diplomat Pharmacy, Inc. of the April 25, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Health Canada is conducting a safety review after issues were discovered during a clinical trial involving rheumatoid arthritis patients being treated with the drug tofacitinib.

Cipher Pharmaceuticals Inc. announced the details of its Q4 2018 financial results conference call on Tuesday, March 19, 2019.

On March 11, Sweet Street founder, CEO and Chief Innovator, Sandy Solmon, was named one of the Women’s Foodservice Forum’s Industry Titans at the WFF Annual Leadership Development Conference.

Health Canada is advising Canadians that the following products may pose serious health risks.

Regulus Therapeutics Inc. announced the resignation of Dr. Timothy Wright, Chief Research and Development Officer, effective March 15, 2019.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC, announces that KSF has commenced an investigation into American Renal Associates Holdings, Inc. on behalf of shareholders that purchased the Company’s shares issued in connection with its April 2016 Initial Public Offering.